[Serum Levels of Several Chemokines in Patients with Rheumatoid Arthritis].

Hua-xiang Wu,Ying Zhang,Yong-liang Zhu
DOI: https://doi.org/10.3760/j:issn:0376-2491.2005.08.009
2005-01-01
Abstract:OBJECTIVE:To explore the role of several chemokines in rheumatoid arthritis (RA) and their clinical significance.METHOD:ELISA was used to detect the serum levels of interleukin (IL)-8, interferon-gamma inducible protein (IP)-10, and RANTES in 58 active RA patients, 29 clinically remissive RA patients, 21 osteoarthritis (OA) patients, and 30 healthy volunteers. Clinical data of these patients were compared between different groups.RESULTS:The serum levels of IL-8, IP-10 and RANTES in the active RA patients were significantly higher than those of the healthy controls and OA patients. The serum level of IP-10 of the active patients was higher than that of the clinically remissive patients. The index IL-8/IP-10 x RANTES/IP-10 of the active patients was higher than that of the healthy controls (P = 0.01). The serum RANTES level was positively correlated with erythrocyte sedimentation rate, C-reactive protein, platelet count, and numbers of swollen joints, and was negatively correlated with the hemoglobin level. The serum level of IP-10 was negatively correlated with X-ray image grade of hand and wrist joints.CONCLUSION:The serum levels of IL-8, IP-10 and RANTES significantly increase in active RA. The level of RANTES may be a useful additional marker for disease activity and the level of IP-10 can be used as an index of prognosis.
What problem does this paper attempt to address?